Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carlos Aliaga Macha"'
Autor:
Rodrigo Motta Guerrero, Veronica Arnao Labajos, Sophia Lozano Ballena, Carlos Aliaga Macha, Miguel Sotelo Lezama, Cristian Pacheco Roman, Paola Montenegro Beltran, Alejandro Figueroa Torrejon
Publikováno v:
ecancermedicalscience. 16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f552f9f0f7e68375853cd7e9e0c5d757
https://doi.org/10.3332/ecancer.2022.1489
https://doi.org/10.3332/ecancer.2022.1489
Autor:
Vladmir C. Cordeiro de Lima, Marcelo Corassa, Erick Saldanha, Helano Freitas, Oscar Arrieta, Luis Raez, Suraj Samtani, Maritza Ramos, Carlos Rojas, Mauricio Burotto, Diego F. Chamorro, Gonzalo Recondo, Alejandro Ruiz-Patiño, Luis Más, Lucia Zatarain-Barrón, Sergio Mejía, José Nicolas Minata, Claudio Martín, Juan Bautista Blaquier, Rodrigo Motta Guerrero, Carlos Aliaga-Macha, Carlos Carracedo, Camila Ordóñez- Reyes, Juan Esteban Garcia-Robledo, Luis Corrales, Carolina Sotelo, Luisa Ricaurte, Nicolas Santoyo, Mauricio Cuello, Elvira Jaller, July Rodríguez, Pilar Archila, Maritza Bermudez, Tatiana Gamez, Alessandro Russo, Lucia Viola, Umberto Malapelle, Diego de Miguel Perez, Christian Rolfo, Rafael Rosell, Andrés F. Cardona
Publikováno v:
Lung Cancer
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Background: Mutations in STK11 (STK11(Mut)) and, frequently co-occurring, KEAP1 mutations (KEAP1(Mut)) are associated with poor survival in metastatic Non-small Cell Lung Cancer (mNSCLC) patients treated with immunotherapy. However, there are limited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0587ac08b6ca19e5e1265e53d4c43f12
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6932
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6932
Autor:
David Heredia, Luis Mas, Andres F. Cardona, Víctor Oyervides, Rodrigo Motta Guerrero, Marco Galvez-Nino, Luis Lara-Mejía, Carlos Aliaga-Macha, Carlos Carracedo, Edgar Varela-Santoyo, Maritza Ramos-Ramírez, David Davila-Dupont, Juan Martínez, Graciela Cruz-Rico, Jordi Remon, Oscar Arrieta
Publikováno v:
SSRN Electronic Journal.
Co-occurring genomic alterations identified downstream main oncogenic drivers have become more evident since the introduction of next-generation sequencing (NGS) analyses at diagnosis and progression. Emerging evidence has stated that co-occurring ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7a85f9d29102b379b124a561a9e0f7b
https://doi.org/10.2139/ssrn.4201844
https://doi.org/10.2139/ssrn.4201844
Publikováno v:
Journal of Clinical Oncology. 38:e21568-e21568
e21568 Background: Tirosine Kinasa Inhibitors (TKI) are the standard treatment in patients with non-small cell lung cancer (NSCLC) harboring EGFR mutation. However, eventually patients will progress to TKI. The aim of this study is to determinate if
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92c6d9a107658ce2c5d755db3c63ad0d
https://doi.org/10.1200/jco.2020.38.15_suppl.e21568
https://doi.org/10.1200/jco.2020.38.15_suppl.e21568
Publikováno v:
Journal of Clinical Oncology. 38:e21522-e21522
e21522 Background: The standard treatment for patients with advance EGFR mutated NSCLC are Tirosine Kinasa inhibitors (TKI), we face in our clinical practice a different profile of toxicity; there is limited data of Inflammatory markers in this espec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::259918f639942e16b3eaed1b6116025f
https://doi.org/10.1200/jco.2020.38.15_suppl.e21522
https://doi.org/10.1200/jco.2020.38.15_suppl.e21522
Publikováno v:
Journal of Clinical Oncology. 37:e14535-e14535
e14535 Background: Inflammatory markers have been used as prognostic factors in multiple malignancies.In cancer patients, critically ill, the utility of these have limited data.The aim of our study is to determine whether neutrophil lymphocyte ratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a82bf35f5afcfae0b7d0aac81880769
https://doi.org/10.1200/jco.2019.37.15_suppl.e14535
https://doi.org/10.1200/jco.2019.37.15_suppl.e14535